Gilead Sciences Stock Market Value
| GILD Stock | USD 104.08 1.88 1.77% |
| Symbol | Gilead |
Gilead Sciences Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Gilead Sciences. If investors know Gilead will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Gilead Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.258 | Dividend Share 3.08 | Earnings Share 0.39 | Revenue Per Share | Quarterly Revenue Growth 0.064 |
The market value of Gilead Sciences is measured differently than its book value, which is the value of Gilead that is recorded on the company's balance sheet. Investors also form their own opinion of Gilead Sciences' value that differs from its market value or its book value, called intrinsic value, which is Gilead Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Gilead Sciences' market value can be influenced by many factors that don't directly affect Gilead Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Gilead Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Gilead Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Gilead Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Gilead Sciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Gilead Sciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Gilead Sciences.
| 01/17/2025 |
| 02/16/2025 |
If you would invest 0.00 in Gilead Sciences on January 17, 2025 and sell it all today you would earn a total of 0.00 from holding Gilead Sciences or generate 0.0% return on investment in Gilead Sciences over 30 days. Gilead Sciences is related to or competes with Amgen, Merck, AbbVie, Johnson Johnson, Bristol Myers, Pfizer, and Eli Lilly. Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of un... More
Gilead Sciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Gilead Sciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Gilead Sciences upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.63 | |||
| Information Ratio | 0.0794 | |||
| Maximum Drawdown | 4.89 | |||
| Value At Risk | (2.23) | |||
| Potential Upside | 1.96 |
Gilead Sciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Gilead Sciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Gilead Sciences' standard deviation. In reality, there are many statistical measures that can use Gilead Sciences historical prices to predict the future Gilead Sciences' volatility.| Risk Adjusted Performance | 0.0668 | |||
| Jensen Alpha | 0.1284 | |||
| Total Risk Alpha | 0.1262 | |||
| Sortino Ratio | 0.0782 | |||
| Treynor Ratio | 0.3858 |
Gilead Sciences Backtested Returns
Gilead Sciences appears to be very steady, given 3 months investment horizon. Gilead Sciences holds Efficiency (Sharpe) Ratio of 0.19, which attests that the entity had a 0.19 % return per unit of risk over the last 3 months. We have found thirty technical indicators for Gilead Sciences, which you can use to evaluate the volatility of the firm. Please utilize Gilead Sciences' Risk Adjusted Performance of 0.0668, downside deviation of 1.63, and Market Risk Adjusted Performance of 0.3958 to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Gilead Sciences holds a performance score of 15. The company retains a Market Volatility (i.e., Beta) of 0.33, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Gilead Sciences' returns are expected to increase less than the market. However, during the bear market, the loss of holding Gilead Sciences is expected to be smaller as well. Please check Gilead Sciences' jensen alpha, potential upside, accumulation distribution, as well as the relationship between the treynor ratio and expected short fall , to make a quick decision on whether Gilead Sciences' current trending patterns will revert.
Auto-correlation | 0.75 |
Good predictability
Gilead Sciences has good predictability. Overlapping area represents the amount of predictability between Gilead Sciences time series from 17th of January 2025 to 1st of February 2025 and 1st of February 2025 to 16th of February 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Gilead Sciences price movement. The serial correlation of 0.75 indicates that around 75.0% of current Gilead Sciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.75 | |
| Spearman Rank Test | 0.53 | |
| Residual Average | 0.0 | |
| Price Variance | 12.85 |
Gilead Sciences lagged returns against current returns
Autocorrelation, which is Gilead Sciences stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Gilead Sciences' stock expected returns. We can calculate the autocorrelation of Gilead Sciences returns to help us make a trade decision. For example, suppose you find that Gilead Sciences has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Gilead Sciences regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Gilead Sciences stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Gilead Sciences stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Gilead Sciences stock over time.
Current vs Lagged Prices |
| Timeline |
Gilead Sciences Lagged Returns
When evaluating Gilead Sciences' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Gilead Sciences stock have on its future price. Gilead Sciences autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Gilead Sciences autocorrelation shows the relationship between Gilead Sciences stock current value and its past values and can show if there is a momentum factor associated with investing in Gilead Sciences.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Gilead Sciences is a strong investment it is important to analyze Gilead Sciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Gilead Sciences' future performance. For an informed investment choice regarding Gilead Stock, refer to the following important reports:Check out Gilead Sciences Correlation, Gilead Sciences Volatility and Gilead Sciences Alpha and Beta module to complement your research on Gilead Sciences. For information on how to trade Gilead Stock refer to our How to Trade Gilead Stock guide.You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Gilead Sciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.